Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05526755 |
|---|---|
| Brief Title: | A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC) (TARGET) |
| First Submitted : | September 1, 2022 |
| First Submitted that Met QC Criteria : | September 1, 2022 |
| First Posted : | September 2, 2022 |
| Last Update Submitted that Met QC Criteria : | May 14, 2024 |
| Last Update Posted : | May 16, 2024 |